2017 Buyer’s Guide

This buyer’s guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

Structural Disease Update

By Ted E. Feldman, MD, MSCAI, FACC, FESC
 

Much progress has been made in recent years in terms of the therapeutic options available for patients with structural heart disease. In this edition of Cardiac Interventions Today, we take a look at how far we have come, where we stand, and what might come next.

Our focus on structural disease intervention opens with a look at the current state of patent foramen ovale (PFO) closure. Marie-France Poulin, MD, and Clifford J. Kavinsky, MD, provide an overview of the 13-year journey to approval for PFO closure in the United States, including the data that have gotten us to this place and the most recent results that will guide the future of this therapy. Next, Drs. Narbeh Melikian and Philip A. MacCarthy discuss the range of percutaneous PFO closure devices that have been in development, are currently commercially available.

Toby Rogers, MD, then details the patient-specific factors and comorbidities for selecting the proper medical therapy and/or closure device to prevent recurrent cryptogenic stroke in patients with PFOs.

We then move to another hot topic in structural disease—left atrial appendage (LAA) closure. Dee Dee Wang, MD, and Marvin H. Eng, MD, review the applications and limitations of TEE and CTA imaging for evaluating patient anatomy, selecting the correct device size, and guiding LAA closure procedures. With the approval of the Watchman device to close LAAs, the optimal antithrombotic regimen and duration after device implantation is still under consideration and could be specific to each patient. Mathieu Lempereur, MD, and Adel Aminian, MD, discuss the roles for antiplatelet agents and non–vitamin K antagonist oral anticoagulants based on the data available to date.

Our secondary focus for this issue is on Access and Closure. First, we have a roundtable discussion with Michael H. Salinger, MD; Hyde M. Russell, MD; Susheel Kodali, MD; and Lowell Satler, MD, who share their thoughts on the use of the crossover approach to vascular closure for transcatheter aortic valve replacement (TAVR). Anthony Wassef, MD, and Asim N. Cheema, MD, then review some of the techniques and technologies available to assist with radial access for percutaneous coronary intervention (PCI) in order to provide the most benefit this approach can offer.

This issue also includes a point/counterpoint Valve Update article in which Paul J. Pearson, MD, asserts that TAVR has evolved as a procedure and is ready to be offered in more centers throughout the United States. Meanwhile, D. Craig Miller, MD, contends that the proliferation of TAVR centers will lead to improper patient selection and warns of the harm that would cause. In our Coding & Reimbursement department, Anne Beekman, RN, examines the recent shift toward outpatient PCI procedures and the benefits and challenges that have been encountered. And finally, we spoke with Saibal Kar, MD, to get his take on current topics surrounding LAA closure and his research on mitral and tricuspid therapies.

This issue summarizes highlights of the recent literature, topics of current interest and controversy, and we hope meets our goal of synthesizing the vast and rapidly expanding interventional literature.

Ted E. Feldman, MD, MSCAI, FACC, FESC
Chief Medical Editor
 citeditorial@bmctoday.com

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.